$100 price hike of lifesaving EpiPens: has the pharmaceutical industry gone too far with overpricing of in-demand medications?

  • Yes, they have.

    The increase in price of EpiPens makes no sense as it is simply encouraging people to turn to alternative sources that are less effective. EpiPens are not a new or revolutionary thing but are essential for saving the lives of many people. Hundreds of people will die because of the increase in price.

  • Yes, the industry is putting profits over people's lives.

    Yes, the pharmaceutical industry has definitely gone too far. It is trying to maximize profits without regard to the people it's supposed to be helping. Pharmaceutical business executives have let their own power get to their heads. They've forgotten about the "service" part of their industry. Perhaps more competition is needed in order to drive the prices back down.

  • Pharmaceutical industry's overpriced has gone overboard in raising prices ov in-demand medications

    In the last couple years, the pharmaceutical industry has arbitrarily raised the prices of in-demand medications in an effort to hike its profits. First, it was increases to cancer and AIDS drugs, from 2500% to 5000%. Now the price of a standard two-pack of EpiPens, for the treatment of allergy-induced anaphylactic shock, has gone from $100 in 2009 to $600 today. Drug companies have gone too far and U.S. citizens will be padding pharmaceutical profits.

  • The pharmaceutical industry has gone too far with overpricing in demand medications

    Yes the pharmaceutical industry has gone too far in this regard. It is discernible that the purpose of medication is to treat illnesses, not to be used as an object of profitability. Medicines and medications do not serve a purpose if the individuals that need them cannot afford them. With this price increase it would seem that the rich, rather than everyone, are the ones with a right to life, as they are the only ones able to obtain the resources necessary to sustain it.

Leave a comment...
(Maximum 900 words)
No comments yet.